Beschreibung:

E3F05 Second Primary Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Stichworte:

Klinische Studie [Dokumenttyp]

Zentralnervensystemtumoren

Hochgeladen am:

16. Juni 2015

DOI:

Für eine Beantragung loggen Sie sich ein.

Lizenz :

Creative Commons BY-NC 3.0 Legacy

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

E3F05 Second Primary Form NCT00978458

INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

StudyEvent: E3F05 Second Primary Form
1. INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

ECOG clinical trial administrative data

ECOG Protocol Number (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

ECOG Patient ID (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

DCI Name

Registration Step

Reporting Period

Second Primary Cancer (Second Primary)

Patient Initials (Last, First)

Participating Group Protocol Number

Institution/Affiliate

Participating Group Patient ID

Data amendment

Please mark an 'X' if data have been amended. (Please circle amended items in red)

Date data amended (s M D Y)

Second primary cancer assessment

Date of Diagnosis of Second Primary Cancer (M D Y)

Site of Second Primary Cancer

Include information on histologic subtype (s Please attach copies of any corroborating pathology reports)

Briefly describe cancer therapy the patient has received prior to the diagnosis of the second primary and other than that given on ECOG protocols

Briefly describe treatment planned or given for the diagnosis of this second primary

Comments

Investigator Signature

Investigator Signature Date (M D Y)

Zum Seitenanfang zurückkehren

Ähnliche Modelle

Zeige ähnliche Modelle

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.